Medicare Enrolled

Dr. Louis Cohen, M.D.

Urology Physician · Sarasota, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
3333 CATTLEMEN RD STE 104, Sarasota, FL 34232
9413791860
In practice since 2005 (20 years)
NPI: 1417955444 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Cohen from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cohen? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Cohen

Dr. Louis Cohen is an urology physician in Sarasota, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Cohen performed 40,834 Medicare services across 3,216 unique beneficiaries.

Between the years covered by Open Payments, Dr. Cohen received a total of $1,571 from 13 pharmaceutical and/or device companies across 33 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Cohen is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 3% volume in FL $1,571 industry payments

Medicare Practice Summary

Medicare Utilization ↗
40,834
Medicare services
Top 3% in FL for urology physician
3,216
Unique beneficiaries
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,042 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Testosterone injection
An injection of testosterone cypionate, a form of testosterone hormone. The dose is measured in milligrams.
36,700 $0 $0
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,426 $91 $218
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
393 $113 $334
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
296 $8 $14
Leuprolide acetate (for depot suspension), 7.5 mg 264 $136 $401
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
250 $2 $7
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
241 $7 $39
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
180 $10 $51
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
162 $171 $421
Urinalysis with microscopic exam
A urine test performed manually that includes examining the sample under a microscope to check for abnormalities.
155 $3 $9
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
137 $38 $150
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
130 $131 $415
Blood creatinine level test
A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function.
89 $5 $15
Transrectal ultrasound of the pelvis
An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures.
49 $25 $104
PSA test (prostate cancer screening)
A blood test that measures the level of prostate-specific antigen to screen for prostate cancer.
49 $19 $51
Prostate gland biopsy
A procedure to remove small samples of tissue from the prostate gland for laboratory examination.
45 $99 $506
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
45 $25 $64
Ultrasound guidance for needle placement
Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure.
42 $24 $115
Ureteral stent insertion via endoscope
A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder.
28 $86 $1,001
PSA test (prostate cancer screening) 27 $18 $53
Endoscopic removal of foreign body, stone, or stent from urethra or bladder
A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item.
21 $231 $519
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
20 $63 $149
Ureteral stone crushing with endoscope
A procedure to break up a stone in the ureter using an endoscope. The endoscope is inserted to locate and crush the stone.
18 $310 $830
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
18 $8 $22
Ureteral stone crushing with stent insertion
An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open.
14 $315 $881
Shock wave crushing of kidney stones
A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body.
12 $438 $1,196
Total testosterone level test
A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women.
12 $25 $71
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
11 $10 $30
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.2% high complexity
91.4% medium
8.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$1,571
Total received (2018-2024)
Avg $224/year across 7 years
Bottom 31% in FL for urology physician
13
Companies
33
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,571 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$387
2023
$20
2022
$273
2021
$17
2020
$16
2019
$394
2018
$464

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$461
PROCEPT BioRobotics Corporation
$186
Retrophin, Inc.
$128
Inspire Medical Systems, Inc.
$128
ABBVIE INC.
$125
Amgen Inc.
$122
Janssen Biotech, Inc.
$119
Ethicon US, LLC
$92
United Service Solutions LLC
$73
Dexcom, Inc.
$67
SANOFI-AVENTIS U.S. LLC
$33
Novo Nordisk Inc
$23
PFIZER INC.
$15
Top 3 companies account for 49.3% of total payments
Associated products mentioned in payments ›
(815) Thiola · AQUABEAM SYSTEM · CHANTIX · Dexcom G6 Transmitter · Erleada · INSPIRE · Levemir · MYRBETRIQ · Myrbetriq · NEUWAVE Flex Microwave Ablation System · PRALUENT · QULIPTA · Repatha · VESICARE
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $4 per 100 Medicare services performed
Looking for an urology physician in Sarasota?
Compare urology physicians in the Sarasota area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
38
Per 100K population
8.5
County median income
$80,633
Nearest hospital
HCA FLORIDA SARASOTA DOCTORS HOSPITAL
3.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Cohen is a mixed practice specialist, with above-average Medicare volume (top 3% in FL), with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Cohen experienced with testosterone injection?
Based on Medicare claims data, Dr. Cohen performed 36,700 testosterone injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cohen receive payments from pharmaceutical companies?
Yes. Dr. Cohen received a total of $1,571 from 13 companies across 33 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cohen's costs compare to other urology physicians in Sarasota?
Dr. Cohen's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cohen) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →